MY8500999A - Amine salt of clavulanic acid its preparation and use - Google Patents

Amine salt of clavulanic acid its preparation and use

Info

Publication number
MY8500999A
MY8500999A MY999/85A MY8500999A MY8500999A MY 8500999 A MY8500999 A MY 8500999A MY 999/85 A MY999/85 A MY 999/85A MY 8500999 A MY8500999 A MY 8500999A MY 8500999 A MY8500999 A MY 8500999A
Authority
MY
Malaysia
Prior art keywords
preparation
amine salt
clavulanic acid
clavulanic
acid
Prior art date
Application number
MY999/85A
Other languages
English (en)
Inventor
Cook Michael Allen
Curzons Alan David
Wilkins Robert Bennett
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10507413&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY8500999(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of MY8500999A publication Critical patent/MY8500999A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MY999/85A 1979-08-24 1985-12-30 Amine salt of clavulanic acid its preparation and use MY8500999A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7929544 1979-08-24

Publications (1)

Publication Number Publication Date
MY8500999A true MY8500999A (en) 1985-12-31

Family

ID=10507413

Family Applications (1)

Application Number Title Priority Date Filing Date
MY999/85A MY8500999A (en) 1979-08-24 1985-12-30 Amine salt of clavulanic acid its preparation and use

Country Status (20)

Country Link
US (1) US4647659A (no)
EP (1) EP0026044B1 (no)
JP (2) JPS5634685A (no)
KR (1) KR860000343B1 (no)
AU (1) AU535198B2 (no)
CA (1) CA1157862A (no)
DE (1) DE3063683D1 (no)
DK (1) DK156069C (no)
ES (1) ES8106157A1 (no)
FI (1) FI67222C (no)
GR (1) GR69870B (no)
HK (1) HK1086A (no)
HU (1) HU185619B (no)
IE (1) IE50047B1 (no)
IL (1) IL60885A (no)
MY (1) MY8500999A (no)
NO (1) NO165241C (no)
NZ (1) NZ194703A (no)
PL (1) PL139811B1 (no)
ZA (1) ZA805206B (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1000035B (el) * 1987-01-29 1990-03-12 Beecham Group Plc Κλαβουλανικο καλιο.
ES2010143A6 (es) † 1989-03-01 1989-10-16 Pharma Mar S A Pharmar Un nuevo procedimiento de obtencion del acido z(2r,5r)-3-(2-hiadroxietiliden)-7- oxo-4-oxa-1-azabiciclo(3,2,0) -heptano-2-carboxilico y de sales estares farmaceutiacamente aceptables del mismo,a partir de caldos de fermentacion de streptomyces, sp.
JPH0457085U (no) * 1990-09-14 1992-05-15
JPH0569557U (ja) * 1992-02-26 1993-09-21 東京電機工業株式會社 固体蓄熱装置
AT400033B (de) * 1992-03-10 1995-09-25 Biochemie Gmbh Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben
AT399155B (de) * 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
AT1447U1 (de) * 1992-06-11 1997-05-26 Smithkline Beecham Plc Neue salze von clavulansäure
SI9300296B (sl) * 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
AT475U1 (de) * 1992-06-11 1995-11-27 Smithkline Beecham Plc Verfahren zur herstellung von clavulansaeure
GB2282810B (en) * 1992-06-11 1997-02-26 Smithkline Beecham Plc Preparation or purification of clavulanic acid
SI9200139A (en) * 1992-07-08 1994-03-31 Lek Tovarna Farmacevtskih New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
KR100200239B1 (ko) * 1992-10-21 1999-06-15 김충환 클라불란산 칼륨염의 제조방법
AT1446U1 (de) * 1992-10-31 1997-05-26 Smithkline Beecham Plc Verfahren zur herstellung und/oder reinigung von clavulansäure
GB9305565D0 (en) * 1993-03-18 1993-05-05 Smithkline Beecham Plc Novel compounds and processes
US5760218A (en) * 1993-03-26 1998-06-02 Gist-Brocades N.V. Diamine salts of clavulanic acid
US5821364A (en) * 1993-03-26 1998-10-13 Gist-Brocades N.V. Diamine salts of clavulanic acid
HUT69372A (en) * 1993-03-26 1995-09-28 Gist Brocades Nv Diamine salts of clarulanic acid, pharmaceutical compositions containing the same and process for their production
DE4318916A1 (de) * 1993-06-07 1994-12-08 Bayer Ag Cyclobutylazole
ATE198892T1 (de) 1993-11-17 2001-02-15 Biochemie Gmbh Trennung von cephalosporinisomeren
GB9401969D0 (en) * 1994-02-02 1994-03-30 Smithkline Beecham Plc Process
GB9426261D0 (en) 1994-12-24 1995-02-22 Spurcourt Ltd Clavulanic acid salts
GB9500977D0 (en) * 1995-01-19 1995-03-08 Smithkline Beecham Plc Novel process
AU691727B2 (en) * 1995-02-25 1998-05-21 Spurcourt Limited Clavulanic acid salts
SI9500134B (sl) 1995-04-20 2004-04-30 Lek, Postopek za pripravo čistih alkalijskih soli klavulanske kisline
KR100200242B1 (ko) * 1995-05-16 1999-06-15 김충환 클라불란산염의 제조 방법
GB9515809D0 (en) * 1995-08-02 1995-10-04 Smithkline Beecham Plc Process
JPH09152148A (ja) * 1995-09-29 1997-06-10 Tokyo Denki Kogyo Kk 蓄熱式空調装置
US6414142B1 (en) * 1996-06-13 2002-07-02 Smithkline Beecham Corporation Process for preparing potassium clavulanate
AT404728B (de) * 1996-11-27 1999-02-25 Biochemie Gmbh Verfahren zur herstellung von clavulansäure-aminsalzen
AU5409799A (en) * 1998-07-03 2000-01-24 Dsm N.V. Fermentation process to produce clavulanic acid at a low concentration of free amino acids
WO2000018947A1 (en) * 1998-09-29 2000-04-06 Dsm N.V. Fermentation of clavulanic acid at a controlled level of ammonia
GB0003305D0 (en) 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
ES2177391B1 (es) * 2000-04-19 2004-08-16 Felipe Lopez Oliva Muñoz Protesis de disco cervical.
CA2408853C (en) * 2000-05-13 2012-01-10 Smithkline Beecham P.L.C. Process
CN105384758B (zh) * 2015-12-01 2018-05-01 国药集团威奇达药业有限公司 克拉维酸胺盐的制备方法
CN109305978A (zh) * 2017-07-26 2019-02-05 山东睿鹰先锋制药有限公司 一种制备克拉维酸盐的新方法
CN108822134B (zh) * 2018-04-25 2021-06-25 国药集团威奇达药业有限公司 克拉维酸叔丁胺盐的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1508977A (en) * 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
NZ177159A (en) * 1974-04-20 1978-03-06 Beecham Group Ltd Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions
GB1543563A (en) * 1975-02-07 1979-04-04 Glaxo Lab Ltd Beta-lactam antibiotic in purified form
YU40452B (en) * 1975-02-07 1986-02-28 Beecham Group Plc Process for the elimination of contaminating impurities from clavulinic acid
GB1578739A (en) * 1976-07-23 1980-11-05 Beecham Group Ltd Amine salts of clavulanic acid methods for their preparation and compositions containing them
GB1572912A (en) * 1977-01-19 1980-08-06 Beecham Group Ltd Clavulanic acid esters
US4255332A (en) * 1977-09-01 1981-03-10 Beecham Group Limited Process for the preparation of potassium clavulanate from lithium clavulanate

Also Published As

Publication number Publication date
DK156069C (da) 1989-12-04
JPH02167286A (ja) 1990-06-27
ES494431A0 (es) 1981-07-16
IE801777L (en) 1981-02-24
CA1157862A (en) 1983-11-29
EP0026044B1 (en) 1983-06-08
PL226397A1 (no) 1981-05-22
NO165241B (no) 1990-10-08
IE50047B1 (en) 1986-02-05
PL139811B1 (en) 1987-02-28
NO802498L (no) 1981-02-25
US4647659A (en) 1987-03-03
FI802590A (fi) 1981-02-25
JPS5634685A (en) 1981-04-06
DK156069B (da) 1989-06-19
IL60885A (en) 1983-11-30
DE3063683D1 (en) 1983-07-14
HU185619B (en) 1985-03-28
NO165241C (no) 1991-01-16
JPH0415234B2 (no) 1992-03-17
ZA805206B (en) 1981-08-26
JPH0234954B2 (no) 1990-08-07
DK363080A (da) 1981-02-25
HK1086A (en) 1986-01-10
IL60885A0 (en) 1980-10-26
KR860000343B1 (ko) 1986-04-12
FI67222B (fi) 1984-10-31
AU535198B2 (en) 1984-03-08
KR830003492A (ko) 1983-06-20
GR69870B (no) 1982-07-20
NZ194703A (en) 1983-09-02
ES8106157A1 (es) 1981-07-16
FI67222C (fi) 1985-02-11
EP0026044A1 (en) 1981-04-01
AU6163280A (en) 1981-04-09

Similar Documents

Publication Publication Date Title
MY8500999A (en) Amine salt of clavulanic acid its preparation and use
IL60906A0 (en) -carbolin-3-carboxylic acid derivatives and methods of preparing the same
PH15907A (en) Novel naphthyridine derivatives and method of use thereof
JPS568380A (en) Quarternary ammonium salt of esterrlactone and its manufacture
DE3072064D1 (en) Amino acid derivatives and their preparation
IL59294A (en) Preparation of alpha-hydroxy-carboxylic acid amides
JPS5645959A (en) Salt of basic dye* its manufacture and use
IL50527A (en) Preparation of clavulanic acid and its salts
GB2047535B (en) Solutions of indoleacetic and indanacetic acid derivatives
JPS5681569A (en) Salt of dihaloo22quinoxalinecarboxylic acid
JPS5498774A (en) Arylethers and acid addition salts of nnalkylpiperidine
IL61039A (en) Preparation of 1-azolyl-1-phenoxy-alkan-2-ones and 1-azolyl-1-halo-alkan-2-ones used therefor
ZA802578B (en) Preparation of aryl-monourethanes and aryl-polyurethanes
PH17486A (en) Preparation of 3-aryl-isoxazoles-5-yl-benzoic acid and salt thereof
NZ192886A (en) Preparation of 7-acylindolin-2-ones and intermediates therein
ZA805383B (en) -carbolin-3-carboxylic acid derivatives and methods of preparing the same
DE3067412D1 (en) D-sesquisodium salt of an oxa-beta-lactam diacid compound and its preparation
DE3064568D1 (en) N-substituted esters of aspartic acid, their preparation and use
KE3577A (en) Amine salt of clavulanic acid,its preparation and use
DE3169452D1 (en) Derivatives of clavulanic acid, their preparation and their use
JPS5635961A (en) Phenylethanolamine derivative and acid addition salt thereof
JPS5495529A (en) Addition salt of sabstituted alalkyl amine* its manufacture and use as medicine
IL60211A0 (en) 3-thienylmalonic acid salt and its preparation
GB2027020B (en) Salts of 5-iodo--3-nitro-4-hydroxybenzonitrile and preparation and use thereof
JPS5692872A (en) 177cyclopropylmethyll144hydroxyy33methoxyy morphinann66one*its acid addition salt and its pharmaceutical use